Company / Capital Returned to Shareholders per Share
CRISPR Therapeutics AG Capital Returned to Shareholders per Share History
FY2018-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.00
FY2018
5-year range
-
FY2018-FY2018
Trend
-
vs FY2017
Sector context
#46 of 51
Health Care
What the data says
Among 51 Health Care companies, CRISPR Therapeutics AG is in the bottom 10% for capital returned to shareholders per share.
Based on SEC 10-K filings.
0.00 in FY2018.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 51This company $0.00 Sector average $2.76
▼
-99.9% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0.00 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2018 · SEC 10-K · Updated Feb 28, 2026